Phibro Animal Health | PAHC - 流动资产

金融业

USD

USD 1.5B

现金及等价物

USD 61.42M

USD 240.42M

USD 935.51M

USD 316.47M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 385.48M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.39B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 534.88M

贸易债权人

USD 127.31M

应收帐款人

USD 215.87M

	流动资产	更改		日
Align Technology	USD 2.66B		7.62M	2026-06
ANI Pharmaceuticals	USD 825.43M		78.35M	2026-06
Aurora Cannabis	CAD 397.45M		48.38M	2026-03
Bristol-Myers Squibb	USD 28.58B		1.37B	2026-06
Canopy Growth	CAD 529.47M		4.8M	2026-03
Corcept Therapeutics	USD 439.68M		13.64M	2026-06
Eli Lilly	USD 64.67B		9.84B	2026-06
Henry Schein	USD 4.6B		104M	2026-06
Idexx Laboratories	USD 1.51B		55.41M	2026-06
Knight Therapeutics	CAD 394.84M		5.86M	2025-12
Merck	USD 36.68B		1.66B	2026-06
Nektar Therapeutics	USD 589.04M		322.77M	2026-03
Pacira	USD 615.21M		100.25M	2026-06
Phibro Animal Health	USD 935.51M		41.44M	2026-06
Prestige Brands	USD 496.81M		65.33M	2026-06
Supernus Pharmaceuticals	USD 723.5M		8.08M	2026-06
Zoetis	USD 6.36B		118M	2026-06